Skip to main content
HRMY logo

Harmony Biosciences Holdings, Inc.

HRMYNASDAQHealthcareBiotechnology

$36.03Today:- (-)1Y +21.72%

As of Oct 22, 2026 close

Market cap
$2.12B
P/E (TTM)
11.68
Forward P/E
11.65
Dividend yield
-
52-week range
$25.81$43.49
Volume (live)
-
Avg. volume (3M)
1.07M

Harmony Biosciences Holdings, Inc. (HRMY) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Harmony Biosciences Holdings, Inc. stock.

Analyst Consensus Rating

Investment consensus from 12 professional research analysts

Consensus Rating

Buy
Based on 12 unique analysts
(16 total ratings in last 90 days)
High Confidence8.0:1 Buy/Sell

Average Price Target

$46.00
+27.67% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest HRMY Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Caroline Palomeque
Ladenburg Thalmann
BuyInitiates
$55.00
Patrick Trucchio
HC Wainwright
BuyReiterates
$55.00
Graig Suvannavejh
Mizuho
BuyMaintains
$51.00
Jason Gerberry
BofA Securities
SellMaintains
$30.00
David Hoang
Deutsche Bank
HoldMaintains
$39.00 → $42.00
Graig Suvannavejh
Mizuho
BuyMaintains
$51.00
Ami Fadia
Needham
BuyMaintains
$50.00
Rudy Li
Wolfe Research
BuyInitiates
$60.00
Patrick Trucchio
HC Wainwright
BuyReiterates
$55.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Danielle Brill
Truist
HoldMaintains
$29.00 → $34.00
Jason Gerberry
BofA Securities
SellReiterates
$28.00 → $30.00
So Youn Shim
UBS
HoldMaintains
$33.00 → $37.00
Rimmi Singhi
Zacks Equity Research
BuyInitiates Coverage
-
Tracey Ryniec
TopStockAnalysts
BuyInitiates Coverage
-

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 16, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for HRMY?

The analyst consensus rating for HRMY is Buy, based on the latest ratings from 12 analysts over the last 90 days.

What is the average price target for HRMY?

The average 12-month price target for HRMY is $46.00, representing an upside of 27.7% from the Oct 22, 2026 close of $36.03.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.